Impax Asset Management Group plc Has $8.23 Million Stock Holdings in The Clorox Company (NYSE:CLX)

Impax Asset Management Group plc lowered its stake in shares of The Clorox Company (NYSE:CLX) by 5.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 50,485 shares of the company’s stock after selling 2,687 shares during the period. Impax Asset Management Group plc’s holdings in Clorox were worth $8,225,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Clorox by 99.8% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,813 shares of the company’s stock worth $7,136,000 after acquiring an additional 22,882 shares in the last quarter. Fidelis Capital Partners LLC bought a new position in shares of Clorox in the 1st quarter worth $63,000. Nordea Investment Management AB lifted its holdings in shares of Clorox by 4.5% in the 1st quarter. Nordea Investment Management AB now owns 9,977 shares of the company’s stock worth $1,519,000 after purchasing an additional 426 shares in the last quarter. Daiwa Securities Group Inc. grew its position in Clorox by 44.2% in the 1st quarter. Daiwa Securities Group Inc. now owns 16,505 shares of the company’s stock valued at $2,527,000 after purchasing an additional 5,056 shares during the period. Finally, Whittier Trust Co. increased its stake in Clorox by 11.7% during the 1st quarter. Whittier Trust Co. now owns 4,451 shares of the company’s stock valued at $681,000 after purchasing an additional 467 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Insider Buying and Selling at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.57% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on CLX shares. TD Cowen assumed coverage on shares of Clorox in a research note on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price objective on the stock. JPMorgan Chase & Co. lifted their price target on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research note on Friday, October 11th. Deutsche Bank Aktiengesellschaft boosted their price objective on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Barclays raised their target price on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a report on Friday, November 1st. Finally, Wells Fargo & Company lowered their price target on Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research report on Wednesday, July 10th. Six investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $151.57.

Clorox Trading Down 0.1 %

NYSE CLX opened at $162.37 on Wednesday. The stock has a market capitalization of $20.10 billion, a price-to-earnings ratio of 56.57, a PEG ratio of 3.11 and a beta of 0.41. The business’s fifty day moving average is $161.75 and its 200-day moving average is $146.46. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The Clorox Company has a one year low of $125.46 and a one year high of $169.09.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the previous year, the company earned $0.49 earnings per share. The company’s quarterly revenue was up 27.0% on a year-over-year basis. Equities research analysts predict that The Clorox Company will post 6.81 EPS for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.01%. The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio is currently 170.03%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.